代谢组学
超重
医学
随机对照试验
内科学
肥胖
2型糖尿病
代谢组
甘油三酯
内分泌学
糖尿病
鞘磷脂
代谢物
胆固醇
生理学
体质指数
生物
食品科学
脂类学
食物频率问卷
疾病
食物摄入量
生物信息学
作者
Angeliki M. Angelidi,Eric Bartell,Yisong Huang,Oana A. Zeleznik,Núria Estanyol-Torres,Michael Y. Mi,Shilpa N. Bhupathiraju,Kelly Ra,Clemens Wittenbecher,Jessica Lasky-Su,Clary B. Clish,D. Ludwig,B. Ebbeling Cara,Joel N. Hirschhorn
标识
DOI:10.1038/s41467-026-68353-z
摘要
Diet plays a crucial role in health, with low-carbohydrate diets often proposed to exert metabolic benefits. We aim to investigate metabolomic adaptations in 164 adults with overweight or obesity who were randomly assigned to high- (n = 54), moderate- (n = 53), or low-carbohydrate (n = 57) diets during a 20-week weight-loss maintenance phase of the Framingham State Food Study [(FS)2], a controlled, parallel feeding trial (ClinicalTrials.gov: NCT02068885). We measure fasting plasma metabolites by liquid chromatography-tandem mass spectrometry using samples from 147 participants who completed the study (n = 45, 48, and 54 in the high-, moderate-, and low-carbohydrate diet groups, respectively). Significant associations (False Discovery Rate<0.05) are identified between carbohydrate-to-fat ratio (CFR) and diet-induced changes in 148 of 479 metabolites at 20 weeks, with nearly all showing consistent trends at 10 and 20 weeks. Phosphatidylcholines plasmanyls/plasmalogens, phosphatidylethanolamines plasmanyls/plasmalogens, and sphingomyelins generally decrease with higher CFR, whereas lysophosphatidylcholines, lysophosphatidylethanolamines, and triglycerides generally increase. Our findings are largely reproducible in an independent feeding trial involving diets with similar CFR (Popular Diets Study, ClinicalTrials.gov: NCT00315354). Eleven triglyceride species (≤3 double bonds), linked to type 2 diabetes risk, increase with higher CFR. Our findings demonstrate metabolomic changes caused by varying CFR dietary patterns, offering potential insights into mechanisms that could guide targeted dietary intervention strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI